Clinical Trial Update: IRESSA™ In Combo With Xeloda™ in Advanced Colorectal Cancer Patients After 1st-Line Chemo Failure [Phase 1, Phase 2]

View source ↗

Summary

The document reports a completed Phase 1/2 trial evaluating gefitinib (IRESSA) in combination with capecitabine (Xeloda) for advanced colorectal cancer after fi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Iressa (gefitinib)
• Xeloda (capecitabine)

Snippet

Sponsor: AstraZeneca | Conditions: Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED